1418280-24-6

Basic information

• Product Name: N-(3-iodo-2-carboxyphenyl)glycine-potassium salt
• Synonyms: N-(3-iodo-2-carboxyphenyl)glycine-potassium salt
• CAS NO: 1418280-24-6
• Molecular Weight: 359.162
• Mol File: 1418280-24-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(3-iodo-2-carboxyphenyl)glycine-potassium salt(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-iodo-2-carboxyphenyl)glycine-potassium salt(1418280-24-6)
• EPA Substance Registry System: N-(3-iodo-2-carboxyphenyl)glycine-potassium salt(1418280-24-6)

Safety Data

• Hazardous Substances Data: 1418280-24-6(Hazardous Substances Data)

Upstream product

• 3926-62-3 sodium monochloroacetic acid 
• 172681-47-9 3-iodo-2-methylphenylamine 
• 172681-48-0 N-(3-iodo-2-methylphenyl)acetamide 
• 1418280-22-4 N-acetyl-6-iodo anthranilic acid 

Relevant articles and documents

Halogenated Phenols for Diagnostics, Antioxidant Protection and Drug Delivery

The present invention provides compositions and methods for the targeted delivery, release and/or formation of a drug compound at a target site(s) within the body of an individual, such as a diseased and/or inflamed tissue in the body of the individual. These compositions may comprise a halogenated phenol ring cleavably linked to a core structure of a drug compound. Due to the variety of substituents that may be utilized in forming the different types of linkages, numerous examples of drug compounds linked to a halogenated phenol ring are proposed. The present invention further provides compositions comprising halogenated phenol starting compounds that do not undergo cleavage during a dehalogenation reaction to form a drug compound in a targeted tissue when administered to an individual. Methods of administering these non-cleaving compounds are further provided.